June 28, 2019
JPMA President Joji Nakayama The Japan Pharmaceutical Manufacturers Association (JPMA) will call on the government to revisit selection criteria for comparator products in new drug pricing towards the next reimbursement policy reform in April 2020, President Joji Nakayama said on...read more